Amneal Pharmaceuticals, Inc. (AMRX)

NMS – Real Time Price. Currency in USD

17.45

+0.35 (2.05%)

Market open: Aug 12, 2026, 2:27 PM EDT

17.05

-0.05 (-0.29%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

3.02B

2.79B

2.39B

2.21B

Cost of goods sold

-1.88B

-1.77B

-1.54B

-1.42B

Gross Profit

1.14B

1.02B

857M

796M

Operating expenses (excl. COGS)

-713M

-667M

-594M

-595M

Operating Income

423M

353M

263M

200M

Non-operating income, total

-284M

-408M

-303M

-449M

Pretax income

139M

-55M

-40M

-248M

Equity in earnings

Taxes

-11M

-19M

-8M

-7M

Non-controlling/minority interest

-56M

-43M

-35M

125M

After tax other income/expense

Net income before discontinued operations

72M

-117M

-84M

-130M

Discontinued operations

Net income

72M

-117M

-84M

-130M

Dilution adjustment

Preferred dividends

Amneal Pharmaceuticals, Inc. (AMRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Amneal Pharmaceuticals, Inc. (AMRX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Amneal Pharmaceuticals, Inc. (AMRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Amneal Pharmaceuticals, Inc. (AMRX)

Income Statement (Annual)

Income Statement (Annual)